Transparency Committee Opinion
GLIVEC
| Date |
23 January 2008 |
Pharmaceutical
formulation |
GLIVEC 100 mg film-coated scored tablets
Pack of 60 tablets (362 247-5)
GLIVEC 400 mg film-coated scored tablets
Pack of 30 tablets (362 249-8)
|
| ATC code |
-
L01XE01
|
| Active ingredient |
imatinib (mesilate)
|
| Laboratory / Manufacturer |
NOVARTIS PHARMA S.A.S. |
| Reason for request |
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals for “the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery”. |
Français
